Target Name: VN1R11P
NCBI ID: G387317
Other Name(s): Vomeronasal 1 receptor 11 pseudogene | hs6V1-2p | Hs6V1-2p | Vomeronasal 1 receptor 4 pseudogene | DJ86C11.7 | VNR6I2P | vomeronasal 1 receptor 11, pseudogene | dJ86C11.7

VN1R11P Gene as Potential Drug Target for Respiratory Diseases

VN1R11P (Vomeronasal 1 receptor 11 pseudogene) is a gene that has been identified as a potential drug target or biomarker for the treatment of various respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea.

The VN1R11P gene is located on chromosome 6 and encodes for a protein known as the vomeronasal receptor 11 (V11R). This protein is a key mediator of the immune response and is involved in the regulation of allergic reactions, as well as the regulation of sleep and wake cycles.

Studies have shown that individuals with mutations in the VN1R11P gene are at increased risk for developing respiratory diseases, including COPD and asthma. Additionally, individuals with mutations in this gene have been shown to have reduced levels of V11R in their airways, which may contribute to the development of these diseases.

Furthermore, research has also shown that V11R plays a role in the regulation of sleep and wake cycles in humans. Studies have shown that individuals with mutations in the VN1R11P gene have altered sleep patterns and are at increased risk of developing sleep disorders.

Given these findings, researchers have identified the VN1R11P gene as a potential drug target or biomarker for the treatment of respiratory diseases. Researchers are currently studying the potential mechanisms of action of drugs that target this gene, with the goal of developing new treatments for respiratory diseases.

In addition, the VN1R11P gene has also been identified as a potential biomarker for the diagnosis of respiratory diseases. By analyzing the levels of V11R in individuals with respiratory diseases, researchers may be able to develop new diagnostic tests for these conditions.

Overall, the VN1R11P gene is a promising target for the development of new drugs and diagnostic tools for respiratory diseases. Further research is needed to fully understand the role of this gene in the regulation of the immune and sleep responses, as well as its potential as a drug target or biomarker.

Protein Name: Vomeronasal 1 Receptor 11, Pseudogene

More Common Targets

VN1R12P | VN1R17P | VN1R18P | VN1R2 | VN1R4 | VN1R46P | VN1R5 | VN1R82P | VN1R91P | VN1R96P | VN2R11P | VN2R1P | VN2R3P | VNN1 | VNN2 | VNN3P | Voltage-dependent anion channels (Porins) | Voltage-dependent calcium channel gamma subunit | Voltage-gated K(v) channel | Voltage-Gated Sodium Channel Complex | Volume-Regulated Anion Channel (VRAC) | VOPP1 | VOR Complex | VPREB1 | VPREB3 | VPS11 | VPS13A | VPS13A-AS1 | VPS13B | VPS13C | VPS13C-DT | VPS13D | VPS16 | VPS18 | VPS25 | VPS26A | VPS26AP1 | VPS26B | VPS26C | VPS28 | VPS29 | VPS33A | VPS33B | VPS35 | VPS35L | VPS36 | VPS37A | VPS37B | VPS37C | VPS37D | VPS39 | VPS41 | VPS45 | VPS4A | VPS4B | VPS50 | VPS51 | VPS51P8 | VPS52 | VPS53 | VPS54 | VPS72 | VPS8 | VPS9D1 | VPS9D1-AS1 | VRK1 | VRK2 | VRK3 | VRTN | VSIG1 | VSIG10 | VSIG10L | VSIG10L2 | VSIG2 | VSIG4 | VSIG8 | VSIR | VSNL1 | VSTM1 | VSTM2A | VSTM2A-OT1 | VSTM2B | VSTM2B-DT | VSTM2L | VSTM4 | VSTM5 | VSX1 | VSX2 | VTA1 | VTCN1 | VTI1A | VTI1B | VTN | VTRNA1-1 | VTRNA1-2 | VTRNA1-3 | VTRNA2-1 | VTRNA3-1P | VWA1 | VWA2